BEIJING, Jan. 25, 2024 /PRNewswire/ — JD Worldwide, the one-stop import and export shopping platform under JD.com, today announced the launch of its first self-operated direct procurement warehouse for fashion goods in Paris, France. This initiative is a key component of the company’s cross-border e-commerce strategy, aiming to facilitate the entry of more European brands… Continue reading JD Worldwide Opens Fashion Goods Warehouse in Paris to Streamline Cross-Border E-commerce for European Brands into China
Category: Newswire
Essity: Year-end Report 2023
STOCKHOLM, Jan. 25, 2024 /PRNewswire/ — JANUARY 1 – DECEMBER 31, 2023 (compared with the corresponding period a year ago) Net sales increased 12.1% to SEK 147,147m (131,320). Sales growth, including organic sales growth and acquisitions, amounted to 6.7%, of which volume accounted for -3.7%, price/mix for 9.5% and acquisitions for 0.9%. Operating profit before… Continue reading Essity: Year-end Report 2023
Essity: Year-end Report 2023
STOCKHOLM, Jan. 25, 2024 /PRNewswire/ — JANUARY 1 – DECEMBER 31, 2023 (compared with the corresponding period a year ago) Net sales increased 12.1% to SEK 147,147m (131,320). Sales growth, including organic sales growth and acquisitions, amounted to 6.7%, of which volume accounted for -3.7%, price/mix for 9.5% and acquisitions for 0.9%. Operating profit before… Continue reading Essity: Year-end Report 2023
SMMT – UK Auto makes one million vehicles and welcomes £23.7 billion investment boost
UK vehicle production tops one million units, up 17.0% in best year since 2019. 905,117 cars and 120,357 commercial vehicles made, with record electrified model output. £23.7 billion of private and public investment commitments announced in 2023. UK must now ramp up EV supply chain and deliver return on investments. LONDON, Jan. 25, 2024 /PRNewswire/ — UK… Continue reading SMMT – UK Auto makes one million vehicles and welcomes £23.7 billion investment boost
USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio
Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., and Bristol Myers Squibb Co. are among the key companies NEW YORK, Jan. 25, 2024 /PRNewswire/ — The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during the forecast period. Increasing awareness campaigns about GIST is a key factor… Continue reading USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio
Essity: Year-end Report 2023
STOCKHOLM, Jan. 25, 2024 /PRNewswire/ — JANUARY 1 – DECEMBER 31, 2023 (compared with the corresponding period a year ago) Net sales increased 12.1% to SEK 147,147m (131,320). Sales growth, including organic sales growth and acquisitions, amounted to 6.7%, of which volume accounted for -3.7%, price/mix for 9.5% and acquisitions for 0.9%. Operating profit before… Continue reading Essity: Year-end Report 2023
MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs
New Contract Expands VA Wound Care Center Access to MolecuLight i:X® and DX™ Point-of-Care Devices that Help Clinicians Manage Infection and Improve Outcomes PITTSBURGH, Pa., Jan. 25, 2024 /CNW/ – MolecuLight Corp., the leader in point-of-care bacterial fluorescence imaging, announced today that the US Department of Veterans Affairs has awarded MolecuLight a Federal Supply Contract for… Continue reading MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs
Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes
HOUSTON, Jan. 25, 2024 /PRNewswire/ — Talos Energy Inc. (“Talos”) (NYSE: TALO) today announced that Talos Production Inc. (the “Company”), a wholly owned subsidiary of Talos, has upsized its previously announced offering (the “Offering”) of $1,250 million in aggregate principal amount of new Second-Priority Senior Secured Notes, consisting of Second-Priority Senior Secured Notes due 2029 and… Continue reading Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes
Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes
HOUSTON, Jan. 25, 2024 /PRNewswire/ — Talos Energy Inc. (“Talos”) (NYSE: TALO) today announced that Talos Production Inc. (the “Company”), a wholly owned subsidiary of Talos, has upsized its previously announced offering (the “Offering”) of $1,250 million in aggregate principal amount of new Second-Priority Senior Secured Notes, consisting of Second-Priority Senior Secured Notes due 2029 and… Continue reading Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes
PRODUCTION AND SALES METRICS FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
JOHANNESBURG , Jan. 25, 2024 /PRNewswire/ — Sasol has published its production and sales performance metrics for the six months ended 31 December 2023 on the Company´s website at www.sasol.com, under the Investor Centre section: https://www.sasol.com/investor-centre/financial-results. For further information, please contact: Sasol Investor Relations, Tiffany Sydow, VP Investor Relations Telephone: +27 (0) 71 673 1929 [email protected] Disclaimer… Continue reading PRODUCTION AND SALES METRICS FOR THE SIX MONTHS ENDED 31 DECEMBER 2023